The generic Carboprost Tromethamine injection used for aborting pregnancy has been released in the US market, said Dr Reddy’s Laboratories.
The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial,the company stated in a filing to BSE.
The product is a generic version of Pfizer’s Hemabate injection in the strength of 250 mcg/mL, it added.
“We are pleased to be first-to-market this product that has been designated as a Competitive Generic Therapy (CGT) by the FDA,” said Marc Kikuchi,CEO, Dr Reddy’s Laboratories North America Generics.
With a CGT designation, the company has 180-day exclusivity to market this product, he added